Jinhai Medical Technology outlines 2026 AGM plans: 20% new issue mandate, 10% buyback, board re-elections

Jinhai Medical Technology Limited has released its circular for the 2026 Annual General Meeting (AGM), scheduled for 15 June 2026 in Shanghai. Key items include refreshed share issue and repurchase mandates, the re-election of four directors, and the proposed re-appointment of ZHONGHUI ANDA CPA Limited as auditor.

AGM logistics • Date & venue: 15 June 2026, 3:00 p.m., 3/F, Block East, 1275 Meichuan Road, Putuo District, Shanghai. • Shareholders must lodge transfers by 4:30 p.m. on 9 June 2026; the register closes from 10–15 June 2026. • Proxy forms are due by 3:00 p.m. on 13 June 2026.

Capital base and proposed authorisations • Current issued share capital: 5.29 billion shares. • Issue Mandate: authority to allot up to 20% of issued shares—approximately 1.06 billion new shares—between the AGM date and the next annual meeting. • Repurchase Mandate: authority to buy back up to 10% of issued shares—about 529.00 million shares—over the same period. • An additional resolution seeks to extend the Issue Mandate by the number of shares actually repurchased. • The board states it has no present intention to exercise either mandate but views the flexibility as beneficial.

Potential shareholding impact Full exercise of the Repurchase Mandate could raise chairman Chen Guobao’s deemed interest (held via Full Fortune International) from 47.83% to 53.14%, which would normally trigger a mandatory general offer under Hong Kong’s Takeovers Code. The board does not intend to repurchase shares to a level that would breach public-float requirements.

Board composition and re-elections • Directors up for re-election: – Li Bin, Executive Director & Co-Chairman (appointed February 2026) – Wang Zhenfei, Executive Director & CEO – Li Yunping, Executive Director – Yang Meihua, Independent Non-Executive Director • The Nomination Committee confirms the independence of all INEDs and recommends the above candidates for re-election.

Auditor re-appointment • ZHONGHUI ANDA CPA Limited proposed for re-appointment for FY2026. • Expected audit fee: HK$1.15–HK$1.20 million, subject to approval by shareholders.

Voting arrangements • All resolutions will be decided by poll in accordance with Listing Rule 13.39(4).

The circular emphasises that the proposed mandates offer strategic flexibility while safeguarding shareholder interests through adherence to Hong Kong regulatory requirements.